Uraemia
Also known as: Uremia
Uraemia is the clinical syndrome produced by retention of nitrogenous and other solutes when kidney function falls to the point at which excretion fails, usually at eGFR below 10 to 15 mL/min/1.73 m2 and a blood urea above 30 to 40 mmol/L, though the severity of symptoms correlates poorly with the urea level. The toxins responsible include guanidino compounds, middle molecules (beta-2 microglobulin), protein bound solutes (indoxyl sulphate, p-cresyl sulphate), advanced glycation end products and inflammatory mediators.
Uraemia affects virtually every organ system through toxin accumulation, volume overload, acidosis, anaemia, platelet dysfunction, secondary hyperparathyroidism and chronic inflammation. It develops over weeks in advanced chronic kidney disease and within days in acute kidney injury with catabolism.
The syndrome is relieved by dialysis or transplantation and often improves partially by correction of reversible contributors: anaemia, acidosis, fluid overload, drugs and infection.













